louisiana glp-1 intestinal paralysis law firm As drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: "Ozempic feet." link in bio 🔗 semaglutide gastroparesis lawsuit in louisiana

503(a) versus 503(b): what it means for you GobyMeds works with both 503(a) and 503(b) certified pharmacy partners

Increasing healthcare awareness, growing disposable incomes, and expanding access to modern therapeutics are accelerating demand for advanced treatment options

But in the beginning of last year, we, we said, no, it has to be for a diabetes prescription. -Senior Human Resources Leader, large services organization The use of GLP-1 agonists was higher than expected for many large employers including for over half (59%) of employers over 5,000 workers Since then, many larger employers covering GLP-1 agonists for weight loss reported higher than expected use of the medications and significant impacts on their prescription spending

To sort through it, I put those questions to Oluwatosin Ajao, MD, an obesity medicine physician known to her patients as Dr

Allison Rhodes is a consultant with Regional Womens Health LLC

Woodward, P